02.15.23 -- Applying Agile Methodologies To Phase 2 Trials

The results of a study are only as good as the data collected. For that reason, clinical data managers (CDMs) are often the unsung heroes of clinical trials. Those managers must ensure the collected data is accurate while avoiding tainted data that can endanger patients, studies, and the reputations of the companies conducting the research.

Delve into the answer to the question: What is the right way to perform decentralized trials in order that they can be controlled and managed effectively?

Driven by necessity, the life sciences industry rapidly shifted to decentralized methods of clinical trial research during the COVID-19 pandemic. Will these changes remain, and, if so, what does this mean for the future of clinical trials?

Explore the logistical risk management factors to consider when deciding to switch to direct-to-patient shipments in the EU.

Phase 2 clinical trials are like software development. How so? Ivanna Rosendal explains the connection and makes the case for using a now-ubiquitous software development workflow to improve clinical data management.

As the focus on precision and personalized medicine continues to increase, the direct-to-patient (DTP) model has emerged as a potential solution. Discover the top three challenges many sponsors face, and how a direct-to-patient pharmacy can provide solutions.

Small or large molecules, simple or complex trials; discover how expertise, purpose-built facilities, and seamless processes can deliver quality with speed and ease.

Explore a step-by-step process to determine whether your clinical trial meets the requirements of the national coverage determination (NCD) for routine costs in clinical trials.

From screening master protocols to the use of data science and artificial intelligence (AI), how can biotech companies achieve the best patient outcomes? Gain insight into three considerations for companies when planning drug development strategies.

The global regenerative medicine market anticipates expanding remarkably due to advancements in technology and growing applications for the treatment of chronic diseases. Listen as regulatory, non-clinical, and clinical experts share current challenges and provide key factors for success.

Trial master file (TMF) quality control is a topic that always seems to be present on conference agendas, and it invokes much discussion and debate. Learn how to best meet the requirements for effective quality control in a trial master file.

How do you define clinical trial expertise and how can you identify expert providers? Look at the signs of clinical trial expertise and explain why those elements are critical to clinical trial success.

When it comes to designing diagnostic clinical trials that are modernized, efficient, executable, and cost-effective, explore why there is a strong need to think and plan beyond standard scientific design.

Get a free preliminary evaluation of your protocol design from a leading CRO in Eastern Europe.

Direct-to-patient clinical supply enables clinical trial participants to receive their treatments in the convenience and comfort of their own home and reduces, or even eliminates, the need to travel to a clinical site.